SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-18-000025
Filing Date
2018-08-02
Accepted
2018-08-02 15:39:00
Documents
79
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q - PCRX - 6.30.18 pcrx-6302018x10xq.htm 10-Q 1093414
2 EXHIBIT 10.1 pcrx-6302018xex101.htm EX-10.1 63612
3 EXHIBIT 10.2 pcrx-6302018xex102.htm EX-10.2 19736
4 EXHIBIT 31.1 pcrx-6302018xex311.htm EX-31.1 14791
5 EXHIBIT 31.2 pcrx-6302018xex312.htm EX-31.2 14808
6 EXHIBIT 32.1 pcrx-6302018xex321.htm EX-32.1 5631
7 EXHIBIT 32.2 pcrx-6302018xex322.htm EX-32.2 5539
14 paciralogoa12.jpg GRAPHIC 63011
  Complete submission text file 0001396814-18-000025.txt   6394345

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pcrx-20180630.xml EX-101.INS 1300588
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20180630.xsd EX-101.SCH 50636
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20180630_cal.xml EX-101.CAL 77825
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20180630_def.xml EX-101.DEF 236317
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20180630_lab.xml EX-101.LAB 675850
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20180630_pre.xml EX-101.PRE 379874
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 18988083
SIC: 2834 Pharmaceutical Preparations